GLP-1 Tirzepatide ReviewS.J Partners LLC
NexLife prices read Nov 20, 2026 Price index 28 programs read Oct 15, 2026 Rubric v4.1 Corrections open log

Provider review

Ro Body tirzepatide review

What Ro Body charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.

Direct answer

Ro Body is not scored on our v4.1 rubric: ro.co returned HTTP 403 to our reads on November 20 and 21, 2026.

Answer last reviewed:
Rubric scoreRubric v4.1 · read the rubric
not scored
Pricing transparency and all-in value—/25
Clinical oversight and care continuity—/20
Pharmacy traceability and quality disclosures—/15
Regulatory clarity and consumer disclosures—/15
State access and operational reliability—/10
Cancellation, billing and support transparency—/10
Evidence quality and data availability—/5
Hatched bars mean no evidence has been captured for that category.Missing evidence scores lower than verified evidence.

What is distinctive about this programme

The annual plan changes the structure, not just the price

Ro's annual prepayment is reported to cut $50 a month from oral medication and $150 a month from injectable medication, and to halve the membership from $149 to $74. That is a larger structural change than most competitors' prepaid discounts, which typically move only the medication line.

On the monthly plan, Zepbound at $399 medication plus $149 membership is $548 all-in — against $449 direct from LillyDirect with no membership. The annual plan closes most of that gap.

Dose escalation applies

Medication prices run $199 to $399 by dose for injectables and $199 to $299 for orals, so the all-in figure moves with titration. The first month is discounted — $299 medication for Zepbound, $149 for oral — and those are introductory rates excluded from our rankings.

What to weigh

Ro is a large, established platform with substantial clinical infrastructure. The pricing question is whether the service layer justifies $1,788 a year on the monthly plan, or $888 on the annual, when both manufacturers sell direct. For patients who want the platform, the annual plan is materially the better structure; for patients who want the medication at the lowest price, LillyDirect and NovoCare are cheaper.

Ro Body — every captured offering, monthlyCaptured 2026-07-06
Semaglutide brand injectable, FDA-$348
Show this figure as a table
What to weigh
ItemValueEvidence
Semaglutide brand injectable, FDA-approved$348Provider-reported
Formulations are not interchangeable. A microdose price is never compared against a standard injectable price, here or anywhere on this site.

Where it holds up

  • Annual plan reduces both medication cost and membership, halving the latter to $74
  • Large established platform with substantial clinical infrastructure
  • Wide brand range including both manufacturers' products

Where it does not

  • $149 monthly membership on the standard plan, $1,788 a year
  • Zepbound at $548 all-in monthly against $449 direct from LillyDirect
  • Medication prices escalate by dose
  • First-month rates are introductory
  • Figures are third-party reported and not yet captured by us
How this provider prices, in one table
How this provider prices, in one table
FieldPosition
MembershipSeparate and required
Dose structureEscalates with dose or not established
Lowest captured figure$348/mo, month-to-month
Evidence statusThird-party reported, pending our own capture
Pharmacy named to usNo — provider-reported only
Every field moves to verified only when a named researcher captures it and archives the source.
How the 100 points are allocatedMethodology v4.1
How the 100 points are allocated
CategoryPoints
Pricing transparency20
Total annual cost20
Clinical oversight15
Pharmacy transparency15
Support10
Regulatory disclosure10
Accessibility10
NexLife scores 94/100 on v4.1. Other providers are pending a v4.1 re-score. Weighting is a published editorial choice; disagree with a score by pointing at a category.

Pricing, all-in

Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.

Ro Body — every captured pricing record
ProviderProgramFormulationDose coverageMedicationRequired feesAll-in monthlyPrice typeEvidenceCaptured
Romonth_to_monthbrand injectable, FDA-approvednot recorded$348not verified$348RecurringProvider-reported2026-07-06

How this sits against the market

The July 2026 all-provider chart that stood here has been retired. Current first-party prices for 28 compounded tirzepatide programs (read October 15, 2026; NexLife November 20, 2026) are on the price index.

What Ro Body charges, component by component
Medication—Membership—Shipping—Dose surcharge—Consultation—Labs—Structure only. No widths are proportional to anything, because nothing is captured.
Show this figure as a table
Data table
ComponentAmount
Medicationnot captured
Membershipnot captured
Shippingnot captured
Dose surchargenot captured
Consultationnot captured
Labsnot captured
All-in totalnot captured
A provider that advertises only the first segment is quoting a price you cannot actually pay.
Where a headline price usually stops short
Where a headline price usually stops short
Cost componentInside the advertised figure?Charged anyway?
Medicationyesyes
Membership or program feenonot verified
Shippingnonot verified
Higher-dose surchargenonot verified
Initial consultationnonot verified
Required laboratory worknonot verified
Cancellation or restocking termsnonot verified
The right-hand column fills in per provider as capture proceeds. Until then it reads unverified, which is the honest state.
Verified price historyVerification pending
no verified captures yet

This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.

Against the category median
All-in monthlyThis provider — not capturedCategory median — not capturedMembership feeThis provider — not capturedCategory median — not capturedRubric scoreThis provider — not capturedCategory median — not capturedThis providerCategory median
Show this figure as a table
Data table
ItemThis providerCategory median
All-in monthlynot capturednot captured
Membership feenot capturednot captured
Rubric scorenot capturednot captured
Medians publish once enough of the comparison set is captured to make a median mean something.

What is included, and what is not

Where it holds up

  • nothing verified yet

Where it does not

  • nothing verified yet

Where it operates

State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.

State research coverage
Researched and verified — 0 (0%)Not yet researched — 51 (100%)51records
Show this figure as a table
Where it operates
StatusRecordsShare
Researched and verified00%
Not yet researched51100%
51 jurisdictions, each researched separately. A shared rule still needs its own source.

Pharmacy and fulfilment

What changed

Verified changes to this provider's terms
no dated events recorded yet
Show this figure as a table
What changed
No events recorded.
Events appear here when something dated actually happens, not to refresh a timestamp.
  • no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.

How this compares to the category

Once enough providers are scored, this section reports where Ro Body sits against the median for each rubric category, not against a hand-picked competitor.

What we have asked Ro, and what they have answered0 of 55 available points unlocked
What we have asked Ro, and what they have answered
QuestionWorthTheir answerStatus
Pharmacy traceability and quality disclosures15 ptsnot verifiedNot answered Verification pending
Clinical oversight and care continuity20 ptsnot verifiedNot answered Verification pending
State access and operational reliability10 ptsnot verifiedNot answered Verification pending
Cancellation, billing and support transparency10 ptsnot verifiedNot answered Verification pending
Blank cells are the answer we have, which is none. This provider can change any row by replying — see the disclosure register for the exact questions and what an answer changes.

Questions readers actually ask

Is Ro Body the cheapest option?

Not scored: ro.co returned HTTP 403 to our reads on November 20 and 21, 2026.

Is compounded tirzepatide the same as Zepbound?

No. Compounded tirzepatide is not FDA-approved, is not generic and is not the same product as Zepbound or Mounjaro; it is made with the drug in those products. Brand Zepbound bought through any platform is the FDA-approved product.

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “Ro Body Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/providers/ro-body/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Report an error
Comparing 0 of 4